Search Result "ibrutinib"
Ibrutinib: A New Frontier in the Treatment of Chronic Lymphocytic Leukemia by Brutonâs Tyrosine Kinase Inhibition
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2013 Page: 265-271
Author(s): Ajoy Lawrence Dias,Dharamvir Jain
Enhanced Oral Bioavailability of Ibrutinib Encapsulated Poly (Lactic-co- Glycolic Acid) Nanoparticles: Pharmacokinetic Evaluation in Rats
Journal: Current Pharmaceutical Analysis
Volume: 15 Issue: 6 Year: 2019 Page: 661-668
Author(s): Abdullah S. Alshetaili,Mohammad J. Ansari,Md. K. Anwer,Majid A. Ganaie,Muzaffar Iqbal,Saad M. Alshahrani,Ahmad S. Alalaiwe,Bader B. Alsulays,Sultan Alshehri,Abdullah Saleh Sultan
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor forTreating Relapsed or Refractory Mantle Cell Lymphoma in Adults
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 30 Year: 2024 Page: 4757-4762
Author(s): Surya K. De
Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 8 Year: 2017 Page: 1040-1045
Author(s): Alessandro Gozzetti,Veronica Candi,Corrado Zuanelli Brambilla,Giulia Papini,Alberto Fabbri,Monica Bocchia
Brutonâs Tyrosine Kinase Signaling and Advancement in Multiple Myeloma Therapy
Ebook: Advances in Cancer Signal Transduction and Therapy
Volume: 1 Year: 2020
Author(s): Krishne Gowda,Max Von Suskil,Omar S. Al-Odat,Jennifer Dang,Kuntal Bhowmick,Prachi S. Narayan,Shantu G Amin
Doi: 10.2174/9789811458118120010009
New Therapies for Chronic Lymphocytic Leukemia
Journal: Current Cancer Therapy Reviews
Volume: 9 Issue: 4 Year: 2013 Page: 245-257
Author(s): Pawel Robak,Tadeusz Robak
Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
Journal: Current Cancer Drug Targets
Volume: 16 Issue: 8 Year: 2016 Page: 701-709
Author(s): Lukas Smolej
Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
Journal: Current Cancer Drug Targets
Volume: 16 Issue: 8 Year: 2016 Page: 710-720
Author(s): Lukas Smolej
CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death
Journal: Current Cancer Drug Targets
Volume: 18 Issue: 6 Year: 2018 Page: 608-616
Author(s): Elisa Mandato,Sara Canovas Nunes,Fortunato Zaffino,Alessandro Casellato,Paolo Macaccaro,Laura Quotti Tubi,Andrea Visentin,Livio Trentin,Gianpietro Semenzato,Francesco Piazza
Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 1 Year: 2016 Page: 2315-2322
Author(s):